Burstable Editorial Team
NewsRamp Burstable Feed
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
24432 articles
Articles
Study Warns Overreliance on AI May Undermine Critical Thinking Skills
A new study suggests that excessive dependence on AI tools like ChatGPT and Claude can compromise critical thinking and independent judgment, with implications for industries such as gaming and beyond.
June 24, 2026Read the full article
Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Emerging Oncology Market
DNA Damage Response inhibitors, led by Onco-Innovations' ONC010, represent a multi-billion dollar opportunity in the expanding oncology market, projected to reach $750 billion by 2030.
June 24, 2026Read the full article
Precious Metal Prices Surge as Four Key Forces Drive Rally in Gold and Silver
Gold and silver prices have rallied significantly, with gold reaching $4,362 per ounce and silver hitting $71.2 per ounce, driven by four key forces that could impact investors and the mining industry.
June 24, 2026Read the full article
Quantum BioPharma Advances Novel MS Treatment Targeting Myelin Repair
Quantum BioPharma is developing Lucid-MS, a first-in-class drug candidate that directly targets myelin sheath repair, aiming to halt multiple sclerosis progression where existing therapies only slow it down.
June 24, 2026Read the full article
Functional Drinks Transition From Niche Trend to Everyday Wellness Staple
Functional beverages are moving beyond specialty stores into daily routines as consumers prioritize clean ingredients, convenience, and integration of hydration with nutrition.
June 24, 2026Read the full article
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Quantum BioPharma is progressing its drug candidate Lucid-MS, a novel nonimmunomodulatory compound that directly protects myelin, into phase 2 clinical trials after filing an IND application with the FDA and completing phase 1 safety studies.
June 24, 2026Read the full article
Beeline Holdings Joins Russell Microcap Index as AI-Driven Mortgage Platform Gains Traction
Beeline Holdings Inc. (NASDAQ: BLNE) has been added to the Russell Microcap Index effective June 29, reflecting its growth in digital mortgage lending with AI underwriting and a focus on gig-economy borrowers.
June 24, 2026Read the full article
Onco-Innovations Advances Novel DNA Damage Response Cancer Therapy with ONC010
Onco-Innovations Limited is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for DNA Damage Response-targeted cancer therapies, with preclinical success and strategic partnerships advancing toward clinical trials.
June 24, 2026Read the full article
Cardio Diagnostics Expands Access to Precision Cardiovascular Tests Through Atlas Healthcare Physicians
Cardio Diagnostics Holdings secures coverage for its AI-powered blood tests through Atlas Healthcare Physicians, broadening access to noninvasive coronary heart disease risk assessment and diagnosis for managed care populations in Southern California.
June 24, 2026Read the full article
Squeeze-Bottle Tahini Capitalizes on Consumer Demand for Simplicity in Pantry Staples
Mighty Sesame Co.'s ready-to-use squeeze-bottle tahini reflects shifting consumer preferences toward convenient, versatile, single-ingredient plant-based foods that fit easily into daily cooking routines.
June 24, 2026Read the full article
Massimo Group Terminates FST Acquisition to Focus on Internal Security Tech Development
Massimo Group (NASDAQ: MAMO) has terminated its proposed acquisition of FST Development Company Limited, citing recent advancements in its internal security technology programs and a $4 million funding commitment from its controlling shareholder to accelerate development of intelligent patrol systems, autonomous vehicles, d...
June 24, 2026Read the full article
Gaxos.ai Sells Gaming Assets for $1.76 Million to Focus on AI Growth
Gaxos.ai divests its gaming portfolio to Game Foundry AI in a stock deal worth $1.76 million, aiming to concentrate resources on its higher-margin AI businesses.
June 24, 2026Read the full article
HH Red Stone's Resident-First Philosophy Challenges Industry Norms in Student Housing Management
HH Red Stone emphasizes treating student housing residents as CEOs to maintain urgency, reputation, and financial performance, a strategy that requires disciplined hiring and scaling to avoid common pitfalls in property management.
June 24, 2026Read the full article
Rail Vision Completes ShuntingYard Field Testing with Israel Railways, Advancing Commercialization
Rail Vision successfully tested its AI-powered ShuntingYard system with Israel Railways, leading to commercialization discussions and expanding potential reach through a partnership with Railserve.
June 24, 2026Read the full article
Ladybug Resource Group's Jingdiao Division Expands Alliance with Mino to Support EV Production Lines
Ladybug Resource Group's Jingdiao division deepens its strategic collaboration with global automation leader Mino, supplying precision components for next-generation electric vehicle manufacturing systems serving major automakers like Tesla, Volkswagen, and BMW.
June 24, 2026Read the full article
Onco-Innovations Engages Nanosoft Polymers to Advance ONC010 Nanoparticle Cancer Therapy
Onco-Innovations Limited partners with Nanosoft Polymers to develop scalable manufacturing processes for its lead nanoparticle-formulated PNKP inhibitor, ONC010, moving toward clinical trials.
June 24, 2026Read the full article
Helus Pharma Prices $50 Million Public Offering to Advance Psychedelic-Inspired Depression and Anxiety Treatments
Helus Pharma announced the pricing of a $50 million public offering to fund Phase 3 trials for its major depressive disorder treatment and other programs, highlighting continued investment in novel serotonergic agonists for mental health.
June 24, 2026Read the full article
Silvercorp Metals Reports 59% Increase in Measured and Indicated Resources at Gaocheng Mine
Silvercorp Metals announced a 59% increase in measured and indicated mineral resource tonnage at its Gaocheng mine, with significant increases in contained silver, lead, and zinc, supporting an extended life-of-mine plan.
June 24, 2026Read the full article
Helus Pharma Surpasses 86% Enrollment in Phase 3 APPROACH Trial for Major Depressive Disorder Treatment
Helus Pharma announced that enrollment in its Phase 3 APPROACH trial evaluating HLP003 for major depressive disorder has exceeded 86%, keeping the company on track to report topline data in Q4 2026.
June 24, 2026Read the full article
Greenland Mines Ltd. Advances North Atlantic Critical Minerals Strategy with Skaergaard and Sarfartoq Projects
Greenland Mines Ltd. is positioning itself as a key player in the critical minerals supply chain with its flagship Skaergaard Project and the pending acquisition of the Sarfartoq rare earth project, supported by an offtake agreement with Neo Performance Materials.
June 24, 2026Read the full article
North Atlantic Titanium Uplists to OTCQB Venture Market and Gains DTC Eligibility
North Atlantic Titanium Corp. has uplisted to the OTCQB Venture Market and received DTC eligibility, enhancing liquidity and U.S. investor access as it advances its Quebec titanium-vanadium project.
June 24, 2026Read the full article